Signe Bech Sørensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Signe Bech Sørensen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Trine Hyrup Mogensen
Aarhus University 1 Department of Biomedicine Aarhus
2 shared publications - Alexandre Belot
Centre International de Recherche en Infectiologie, Inserm, U1111, CNRS, UMR5308, École Normale Supérieure de Lyon, Lyon, France
1 shared publication Andreas Ronit
1 shared publicationAnn-Britt Eg Hansen
1 shared publicationCasper Roed
1 shared publication- Christophe Parizot
Department of Immunology, AP-HP Hôpital Pitié-Salpêtrière, Sorbonne University, Paris, France
1 shared publication
Latest Publications
- Open Access
- 8 January 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (2)
Shared TCR Vβ21.3+ T cell immunological signature between MIS-A and MIS-C
Multisystem inflammatory syndrome (MIS) is a severe and potentially life-threatening complication of SARS-CoV-2 infection that affects both children (MIS-C) and adults (MIS-A). While the inflammatory response in MIS-C has been studied in detail, the immune dysregulation underlying MIS-A remains poorly understood, mainly due to the rarity of its condition. Using flow cytometry, we analyzed the T cell response in two, Danish and French, MIS-A cohorts, encompassing a total of 16 cases. We observed an expansion of Vβ21.3+ T cells in at least one of the major T cell subsets (CD3+, CD4+, or CD8+) in 9 out of 16 MIS-A patients. Vβ21.3+ T cells showed increased expression of activation and exhaustion markers along with a higher abundance of effector memory T cells compared to their Vβ21.3-negative counterparts in patients with or without Vβ21.3 expansion. These findings demonstrate that MIS-A shares the same Vβ21.3+ T cell signature previously reported in MIS-C, suggesting a shared pathological immune-related mechanism between the two conditions.
- 8 January 2026
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 2 (2)
Open AccessShared TCR Vβ21.3+ T cell immunological signature between MIS-A and MIS-C
Multisystem inflammatory syndrome (MIS) is a severe and potentially life-threatening complication of SARS-CoV-2 infection that affects both children (MIS-C) and adults (MIS-A). While the inflammatory response in MIS-C has been studied in detail, the immune dysregulation underlying MIS-A remains poorly understood, mainly due to the rarity of its condition. Using flow cytometry, we analyzed the T cell response in two, Danish and French, MIS-A cohorts, encompassing a total of 16 cases. We observed an expansion of Vβ21.3+ T cells in at least one of the major T cell subsets (CD3+, CD4+, or CD8+) in 9 out of 16 MIS-A patients. Vβ21.3+ T cells showed increased expression of activation and exhaustion markers along with a higher abundance of effector memory T cells compared to their Vβ21.3-negative counterparts in patients with or without Vβ21.3 expansion. These findings demonstrate that MIS-A shares the same Vβ21.3+ T cell signature previously reported in MIS-C, suggesting a shared pathological immune-related mechanism between the two conditions.
- 25 May 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (6) , 1-5
NF-κB Activation and X-Inactivation in Females with Incontinentia Pigmenti and Recurrent Infections
- 25 May 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (6) , 1-5
NF-κB Activation and X-Inactivation in Females with Incontinentia Pigmenti and Recurrent Infections